Terms: = Uterine cancer AND Ki-67 AND Prognosis
139 results:
1. Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer.
Wu J; Wang R; Chen W; Wu Y; Xiao L
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():210-216. PubMed ID: 38301499
[TBL] [Abstract] [Full Text] [Related]
2. Neuroendocrine carcinoma of the uterine cervix with extensive pagetoid spread pattern.
Sakurai A; Yamanoi K; Yamaguchi K; Hamanishi J; Minamiguchi S; Mandai M
J Obstet Gynaecol Res; 2024 Apr; 50(4):758-763. PubMed ID: 38297984
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Factors for uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
4. Fortuitously detected primary ovarian carcinoid tumor: A case report.
Choi HY; Pak MG; Park JW
Medicine (Baltimore); 2023 Aug; 102(31):e34391. PubMed ID: 37543794
[TBL] [Abstract] [Full Text] [Related]
5. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
[TBL] [Abstract] [Full Text] [Related]
6. T
Li S; Liu J; Guo R; Nickel MD; Zhang Y; Cheng J; Zhu J
NMR Biomed; 2023 Aug; 36(8):e4918. PubMed ID: 36914267
[TBL] [Abstract] [Full Text] [Related]
7. LMCD1-AS1 Facilitates Cell Proliferation and EMT by Sponging miR-873-3p in Cervical cancer.
Liang M; Li Y; Chen C
Crit Rev Eukaryot Gene Expr; 2023; 33(2):13-25. PubMed ID: 36734854
[TBL] [Abstract] [Full Text] [Related]
8. Expression of fascin in association with p16 and ki-67 in cervical lesions: immunohistochemical study.
Csizmár S; Výbohová D; Mešt'anová V; Krajňáková B; Kajo K; Kunertová L; Adamkov M
Pol J Pathol; 2022; 73(3):208-214. PubMed ID: 36734435
[TBL] [Abstract] [Full Text] [Related]
9. The analysis of hormonal status and vascular and cell proliferation in endometrioid endometrial adenocarcinomas.
Drocaş I; Crăiţoiu Ş; Stepan AE; Iliescu DG; Drocaş IA; Stepan MD
Rom J Morphol Embryol; 2022; 63(1):113-120. PubMed ID: 36074674
[TBL] [Abstract] [Full Text] [Related]
10. Immunohistochemical Study of ki-67 in Hyperplastic and Endometrium Carcinoma: A Comparative Study.
Ghalib Farhood R; Abd Ali Al-Humairi I
Arch Razi Inst; 2022 Feb; 77(1):229-234. PubMed ID: 35891746
[TBL] [Abstract] [Full Text] [Related]
11. Clinical significance of CD34, podoplanin and ki-67 expression in patients with locally advanced squamous cell cervical carcinoma.
Kubik S; Jesionek-Kupnicka D; Stawiski K; Fijuth J; Moszynska-Zielinska M; Kuncman L; Pajdzinski M; Gottwald L
J Obstet Gynaecol; 2022 Aug; 42(6):2248-2254. PubMed ID: 35264072
[TBL] [Abstract] [Full Text] [Related]
12. PAX9 functions as a tumor suppressor gene for cervical cancer via modulating cell proliferation and apoptosis.
Liu J; Wang YQ; Niu HB; Zhang CX
Kaohsiung J Med Sci; 2022 Apr; 38(4):357-366. PubMed ID: 34931758
[TBL] [Abstract] [Full Text] [Related]
13. uterine smooth muscle tumors of uncertain malignant potential (STUMP): A retrospective study in a single center.
Zhang C; Gao J; Lu S; Zhang Y; Zhu H
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():74-79. PubMed ID: 34467879
[TBL] [Abstract] [Full Text] [Related]
14. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
[TBL] [Abstract] [Full Text] [Related]
15. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial cancer Recurrence].
Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
[TBL] [Abstract] [Full Text] [Related]
16. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
[TBL] [Abstract] [Full Text] [Related]
17. Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma.
Kobayashi N; Takeda Y; Okubo N; Suzuki A; Tokuhisa M; Hiroshima Y; Ichikawa Y
Cancer Sci; 2021 May; 112(5):1936-1942. PubMed ID: 33453146
[TBL] [Abstract] [Full Text] [Related]
18. miR-497-5p Decreased Expression Associated with High-Risk Endometrial cancer.
Fridrichova I; Kalinkova L; Karhanek M; Smolkova B; Machalekova K; Wachsmannova L; Nikolaieva N; Kajo K
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374439
[TBL] [Abstract] [Full Text] [Related]
19. High amplification of PVT1 and MYC predict favorable prognosis in early ovarian carcinoma.
Yamamoto A; Kurata M; Yamamoto K; Nogawa D; Inoue M; Ishibashi S; Ikeda M; Miyasaka N; Kitagawa M
Pathol Res Pract; 2020 Nov; 216(11):153175. PubMed ID: 32841774
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic Role of Krüppel-Like Factors 5, 9, and 11 in Endometrial Endometrioid cancer.
Viola L; Londero AP; Bertozzi S; Orsaria M; Marzinotto S; Antoniazzi F; Renda V; Cinel J; Fruscalzo A; Lellé RJ; Mariuzzi L
Pathol Oncol Res; 2020 Oct; 26(4):2265-2272. PubMed ID: 32451988
[TBL] [Abstract] [Full Text] [Related]
[Next]
